Journal of Emergency Health Care
Formerly known as: International Journal of Medical Investigation
Volume 14, Issue 1 (2-2025)
J Emerg Health Care 2025, 14(1): 1-6 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kaviani M, Rasoulzadeh N, Keshavarz F, hosseinzadeh F, Haddadi R. "Evaluation of the Effect of COVID-19 Vaccine in Preventing COVID-19 Infection in Hemodialysis Patients". J Emerg Health Care 2025; 14 (1) :1-6
URL: http://intjmi.com/article-1-1261-en.html
URL: http://intjmi.com/article-1-1261-en.html
Department of Medical-Surgical Nursing, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran
Abstract: (263 Views)
Abstract
Introduction: The COVID-19 disease caused a global pandemic in a short period of time. One of the reasons for the high prevalence of this disease, especially in Iran, was the lack of a vaccine to prevent the disease. Because, due to the drugs used and the hemodialysis method, these patients were more susceptible to COVID-19 disease. Therefore, this study was conducted with the aim of "Evaluation of the Effect of COVID-19 Vaccine in Preventing COVID-19 Infection in Hemodialysis Patients"
Methodology: This cross-sectional descriptive study was conducted on 240 hemodialysis patients referred to hospitals of Tehran University of Medical Sciences in 2023 using cluster sampling. The data collection tool was a checklist of vaccination history, type of vaccine, number of vaccine doses, and history of COVID-19 infection. The information was collected through self-reporting and entered into SPSS21 statistical software. Descriptive statistics (table, mean, standard deviation) and inferential statistics (Fisher's test) were used for data analysis.
Results: 2.39% of hemodialysis patients contracted COVID-19. The infection rate was lower in those who had received a full vaccine dose. 35.4% of patients had received the AstraZeneca vaccine. The effectiveness of the Sputnik vaccine was lower than other vaccines.
Conclusion: Given that hemodialysis patients are considered to be a susceptible and high-risk group in terms of contracting COVID-19, completing the COVID vaccine dose is considered essential. In this group of patients, the type of vaccine should be selected based on the patient's antibody level, as recommended by a physician.
Introduction: The COVID-19 disease caused a global pandemic in a short period of time. One of the reasons for the high prevalence of this disease, especially in Iran, was the lack of a vaccine to prevent the disease. Because, due to the drugs used and the hemodialysis method, these patients were more susceptible to COVID-19 disease. Therefore, this study was conducted with the aim of "Evaluation of the Effect of COVID-19 Vaccine in Preventing COVID-19 Infection in Hemodialysis Patients"
Methodology: This cross-sectional descriptive study was conducted on 240 hemodialysis patients referred to hospitals of Tehran University of Medical Sciences in 2023 using cluster sampling. The data collection tool was a checklist of vaccination history, type of vaccine, number of vaccine doses, and history of COVID-19 infection. The information was collected through self-reporting and entered into SPSS21 statistical software. Descriptive statistics (table, mean, standard deviation) and inferential statistics (Fisher's test) were used for data analysis.
Results: 2.39% of hemodialysis patients contracted COVID-19. The infection rate was lower in those who had received a full vaccine dose. 35.4% of patients had received the AstraZeneca vaccine. The effectiveness of the Sputnik vaccine was lower than other vaccines.
Conclusion: Given that hemodialysis patients are considered to be a susceptible and high-risk group in terms of contracting COVID-19, completing the COVID vaccine dose is considered essential. In this group of patients, the type of vaccine should be selected based on the patient's antibody level, as recommended by a physician.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |